Research location

Durango

Durango, Mexico

Published trials36

Site observations38

Linked trials published36

Page1 / 1

Research activity in Durango

Durango, Mexico

CureCurrent currently publishes aggregate city-level research activity for this location: 36 trials and 38 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Durango

36 linked trials · page 1 of 1

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular DiseaseNCT05882045 · 2023-05-30 · 1 site observation

Magnesium Lactate in the Reduction of Gestational Diabetes Incidence.NCT04037098 · 2022-07-31 · 1 site observation

Non-Pharmacologic Alternatives for Childhood ObesityNCT03670875 · 2021-07-31 · 1 site observation

A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT02546700 · 2015-09-17 · 1 site observation

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesNCT01606007 · 2012-07-01 · 1 site observation

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation

24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseNCT01316913 · 2011-03-01 · 1 site observation

A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerNCT01137474 · 2010-07-01 · 1 site observation

Comparison of NN1250 With Insulin Glargine in Type 2 DiabetesNCT01006291 · 2009-11-01 · 1 site observation

Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on MetforminNCT01006603 · 2009-10-01 · 1 site observation

Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mgNCT00918138 · 2009-08-01 · 2 site observations

An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 DiabetesNCT00960076 · 2009-08-01 · 1 site observation

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesNCT00859898 · 2009-04-01 · 1 site observation

Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesNCT00838903 · 2009-02-01 · 1 site observation

Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 DiabetesNCT00736879 · 2008-09-22 · 1 site observation

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal ImpairmentNCT00663260 · 2008-06-01 · 1 site observation

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsNCT00707993 · 2008-06-01 · 1 site observation

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseNCT00528372 · 2007-09-01 · 1 site observation

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneNCT00528879 · 2007-09-01 · 1 site observation

A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. MetforminNCT00386100 · 2006-10-01 · 1 site observation

Magnesium and Metabolic SyndromeNCT00603499 · 2006-07-01 · 1 site observation

A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasNCT00313313 · 2006-04-01 · 1 site observation

A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusNCT00263276 · 2005-12-01 · 1 site observation

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.NCT00269828 · 2005-12-01 · 1 site observation

Study In People With Type 2 DiabetesNCT00196989 · 2005-09-01 · 1 site observation

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneNCT00121667 · 2005-08-01 · 1 site observation

Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseNCT00121641 · 2005-07-01 · 1 site observation

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected SubjectsNCT00096746 · 2004-11-01 · 1 site observation

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 DiabetesNCT00359112 · 2004-02-01 · 1 site observation

Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast CancerNCT00075270 · 2004-01-01 · 1 site observation

Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or HyperlipidemiaNCT00668109 · 2003-12-01 · 1 site observation

PPAR-COMBO With SulfonylureaNCT00162175 · 2003-07-01 · 1 site observation

PPAR - Combination With MetforminNCT00162240 · 2003-06-01 · 1 site observation

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic ControlNCT00246987 · 2003-06-01 · 1 site observation

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskNCT00056407 · 2003-03-01 · 2 site observations

Rosiglitazone on Microalbuminuria in Type 2 DiabeticsNCT00500955 · 2000-04-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.